文献速递脑血管病外科神经重症

亲水聚合物与磷酸胆碱涂层血流导向装置在单一抗血小板治疗下治疗破裂颅内动脉瘤的系统文献综述与Meta分析

A Systematic Literature Review and Meta-Analysis of the Treatment of Ruptured Intracranial Aneurysms with Hydrophilic Polymer and Phosphorylcholine-Coated Flow Diverters Under Single Antiplatelet Therapy.
PubMed 文献 · World Neurosurg · 2022-11-30

该系统综述与Meta分析纳入截至2022年3月的5项回顾性观察研究、43例患者46个动脉瘤,评估涂层血流导向装置在单一抗血小板治疗下治疗破裂颅内动脉瘤的安全性。汇总血栓栓塞并发症风险23.9%(95%CI 9.6-47.9)、出血并发症9.4%(95%CI 3.6-22.6)、总体并发症28.3%(95%CI 12.4-52.5),无发表偏倚,研究间异质性低至中等。所有并发症均发生于阿司匹林单一抗血小板治疗患者,作者认为该治疗可行但血栓栓塞并发症发生于相当数量患者。

要点

  • 5项回顾性观察研究共43例患者46个动脉瘤,采用涂层血流导向装置联合单一抗血小板治疗。
  • 血栓栓塞并发症汇总风险23.9%(95%CI 9.6-47.9),出血并发症9.4%(95%CI 3.6-22.6)。
  • 所有并发症均发生于阿司匹林单一抗血小板治疗患者,动脉瘤充分闭塞率65.5%。

核心结论

  • 涂层血流导向装置在单一抗血小板治疗下治疗破裂动脉瘤是可行的。
  • 出血并发症风险低,但血栓栓塞并发症发生于相当数量患者,且均发生于阿司匹林单一抗血小板治疗下。

研究设计与样本

  • 遵循PRISMA的系统综述与Meta分析,检索3个主要数据库截至2022年3月。
  • 两名评价者独立筛选临床研究,采用随机效应模型合并比例进行安全性结局分析。
  • 共纳入5项回顾性观察研究,报告43例患者46个动脉瘤。

主要发现

  • 16%患者植入超过1枚支架,53.8%患者行额外弹簧圈栓塞。
  • 86%患者使用某种阿司匹林方案的单一抗血小板治疗,抗血小板方案总体多变。
  • 血栓栓塞并发症汇总风险23.9%(95%CI 9.6-47.9),出血并发症9.4%(95%CI 3.6-22.6),总体并发症28.3%(95%CI 12.4-52.5)。
  • 未检出发表偏倚,研究间异质性低至中等。
  • 65.5%患者描述为动脉瘤充分闭塞。

局限性

  • 纳入研究为少数回顾性观察研究,异质性中等。
  • 纳入患者数量有限,且接受的单一抗血小板治疗方案多变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Flow diverters coated with antithrombogenic substances were recently introduced and have shown encouraging results in the preclinical setting. Our aim was to analyze their clinical application in patients with ruptured intracranial aneurysms using single antiplatelet therapy (SAPT). METHODS: We performed a PRISMA-compliant systematic review and meta-analysis covering 3 major data bases until March 2022.Two reviewers independently reviewed clinical studies for eligibility.Random-effects analysis of proportions was used to pool safety outcomes (hemorrhagic, thrombembolic, and overall complications). Studies were tested for publication bias and heterogeneity. RESULTS: Five studies reporting 43 patients with 46 aneurysms were identified. More than 1 stent was implanted in 16%, and additional coil embolization was performed in 53.8% of patients. SAPT with one of various acetylsalicylic acid regimens was used in 86%, altogether antiplatelet protocols were variable. The pooled risks of thromboembolic (23.9%; 95% confidence interval [CI], 9.6-47.9), hemorrhagic (9.4%; 95% CI, 3.6-22.6), and overall complications (28.3%; 95% CI, 12.4-52.5) were calculated in the absence of publication bias with low to moderate study heterogeneity measures. All complications occurred in patients under acetylsalicylic acid SAPT. Adequate aneurysm occlusion was described in 65.5% of patients.few retrospective observational studies with moderate heterogeneity, encompassing a limited number of patients treated with variable SAPT regimens. CONCLUSIONS: Flow diversion for ruptured aneurysms under SAPT with coated stents is feasible. Although the risk of hemorrhagic complications was low, thromboembolic complications occurred in a significant number of patients, all under ASA SAPT.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Gawlitza M, Klisch J, Kaiser DPO, et al. A Systematic Literature Review and Meta-Analysis of the Treatment of Ruptured Intracranial Aneurysms with Hydrophilic Polymer and Phosphorylcholine-Coated Flow Diverters Under Single Antiplatelet Therapy. World Neurosurg. 2022. PMID: 36462697. doi:10.1016/j.wneu.2022.11.129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。